We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is ten... Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis. Show more
WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...
WALTHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc.ย (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...
WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...
WALTHAM, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc.ย (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...
WALTHAM, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 0.93896713615 | 6.39 | 6.72 | 6.23 | 4933091 | 6.42492512 | CS |
4 | -0.86 | -11.7647058824 | 7.31 | 7.87 | 6.23 | 5230100 | 6.96850956 | CS |
12 | -2.65 | -29.1208791209 | 9.1 | 10.13 | 6.23 | 5551628 | 8.17613415 | CS |
26 | 2.91 | 82.2033898305 | 3.54 | 10.13 | 3.43 | 5867156 | 7.13660212 | CS |
52 | 1.8 | 38.7096774194 | 4.65 | 10.13 | 3.16 | 5867187 | 5.51084978 | CS |
156 | -1.9 | -22.754491018 | 8.35 | 10.13 | 0.4902 | 6802522 | 3.02520935 | CS |
260 | 3.12 | 93.6936936937 | 3.33 | 10.4343 | 0.4902 | 4389216 | 3.28629887 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions